• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义生殖遗传携带者筛查的核心结局:澳大利亚和新西兰利益相关者的德尔菲调查。

Defining core outcomes of reproductive genetic carrier screening: A Delphi survey of Australian and New Zealand stakeholders.

机构信息

Graduate School of Health, University of Technology Sydney, Sydney, New South Wales, Australia.

出版信息

Prenat Diagn. 2023 Aug;43(9):1150-1165. doi: 10.1002/pd.6410. Epub 2023 Aug 1.

DOI:10.1002/pd.6410
PMID:37526246
Abstract

OBJECTIVE

Understanding the value, benefits and harms of health interventions is needed to inform best practice and ensure responsible implementation of new approaches to patient care. Such value is demonstrated through the assessment of outcomes; however, which outcomes are assessed is often highly varied across studies and can hinder the ability to draw robust conclusions. The Core Outcome Development for Carrier Screening study aims to understand the outcomes that can meaningfully capture the value of reproductive genetic carrier screening (RGCS).

METHOD

The authors report an iterative, two-round online Delphi survey of Australian and New Zealand stakeholders to determine the degree of consensus regarding the core outcomes of RGCS. Panellists ranked 83 outcomes according to their perceived importance on a nine-point Likert scale. Using the distribution of rankings, outcomes were grouped into tiers representative of their perceived level of importance and agreement between groups.

RESULTS

The top tier outcomes represent those agreed to be critically important for all future studies of RGCS to assess and were used to define a preliminary core outcome set encompassing the domains (1) primary laboratory outcomes, (2) pregnancy outcomes, (3) resource use and, (4) perceived utility of RGCS.

CONCLUSION

These findings can guide the selection of meaningful outcomes in studies aiming to demonstrate the value of RGCS. A future international consensus process will expand on these findings and guide the inclusion of diverse perspectives across the range of settings in which RGCS is offered.

摘要

目的

为了指导最佳实践并确保负责任地实施新的患者护理方法,需要了解卫生干预措施的价值、益处和危害。这种价值是通过评估结果来体现的;然而,在研究中,评估哪些结果往往差异很大,这可能会阻碍得出强有力的结论的能力。生殖遗传携带者筛查核心结局开发研究旨在了解能够有意义地捕捉生殖遗传携带者筛查 (RGCS) 价值的结果。

方法

作者报告了一项针对澳大利亚和新西兰利益相关者的迭代式、两轮在线德尔菲调查,以确定 RGCS 核心结局的共识程度。小组成员根据其在 9 分李克特量表上的感知重要性对 83 项结果进行了排名。根据排名的分布,将结果分为不同的层次,以代表其感知的重要性水平和组间的一致性。

结果

排在前几位的结果代表着所有未来 RGCS 研究都认为非常重要的评估结果,用于定义一个初步的核心结果集,涵盖以下领域:(1)主要实验室结果,(2)妊娠结果,(3)资源使用情况,以及(4)RGCS 的感知效用。

结论

这些发现可以指导旨在证明 RGCS 价值的研究中选择有意义的结果。未来的国际共识过程将扩展这些发现,并指导在提供 RGCS 的各种环境中纳入多样化的观点。

相似文献

1
Defining core outcomes of reproductive genetic carrier screening: A Delphi survey of Australian and New Zealand stakeholders.定义生殖遗传携带者筛查的核心结局:澳大利亚和新西兰利益相关者的德尔菲调查。
Prenat Diagn. 2023 Aug;43(9):1150-1165. doi: 10.1002/pd.6410. Epub 2023 Aug 1.
2
The Core Outcome DEvelopment for Carrier Screening (CODECS) study: protocol for development of a core outcome set.核心携带者筛查结局发展(CODECS)研究:核心结局集制定的方案。
Trials. 2021 Jul 22;22(1):480. doi: 10.1186/s13063-021-05439-7.
3
Core outcome set for studies investigating management of selective fetal growth restriction in twins.针对双胎选择性胎儿生长受限管理研究的核心结局集。
Ultrasound Obstet Gynecol. 2020 May;55(5):652-660. doi: 10.1002/uog.20388. Epub 2020 Mar 29.
4
Systematic review of outcomes in studies of reproductive genetic carrier screening: Towards development of a core outcome set.生殖遗传携带者筛查研究结局的系统评价:建立核心结局集的探索。
Genet Med. 2022 Jan;24(1):1-14. doi: 10.1016/j.gim.2021.08.005. Epub 2021 Nov 30.
5
The Core Rehabilitation Outcome Set for Single-Sided Deafness (CROSSSD) study: International consensus on outcome measures for trials of interventions for adults with single-sided deafness.单侧聋核心康复结局集(CROSSSD)研究:成人单侧聋干预试验结局测量的国际共识。
Trials. 2022 Sep 8;23(1):764. doi: 10.1186/s13063-022-06702-1.
6
Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment.开发用于后部非感染性葡萄膜炎临床试验的核心结局集。
Ophthalmology. 2021 Aug;128(8):1209-1221. doi: 10.1016/j.ophtha.2021.01.022. Epub 2021 Jan 28.
7
Prioritisation of clinical trial learning needs of musculoskeletal researchers: an inter-disciplinary modified Delphi study by the Australia & New Zealand musculoskeletal clinical trials network.肌肉骨骼系统临床研究人员临床试验学习需求的优先级排序:澳大利亚和新西兰肌肉骨骼临床研究网络的跨学科改良德尔菲研究。
BMC Med Educ. 2024 Jul 8;24(1):735. doi: 10.1186/s12909-024-05732-4.
8
Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting.用于急性髓细胞白血病未来临床试验的核心结局测量:使用多利益相关者共识 Delphi 过程和最终共识会议的 HARMONY 研究方案。
Trials. 2020 May 27;21(1):437. doi: 10.1186/s13063-020-04384-1.
9
Incorporating patient perspectives in the development of a core outcome set for reproductive genetic carrier screening: a sequential systematic review.将患者观点纳入生殖遗传携带者筛查的核心结局集制定中:一项序贯系统评价。
Eur J Hum Genet. 2022 Jul;30(7):756-765. doi: 10.1038/s41431-022-01090-1. Epub 2022 Mar 28.
10
Methodology in core outcome set (COS) development: the impact of patient interviews and using a 5-point versus a 9-point Delphi rating scale on core outcome selection in a COS development study.核心结局集(COS)开发中的方法学:患者访谈以及使用 5 点和 9 点 Delphi 评分量表对 COS 开发研究中核心结局选择的影响。
BMC Med Res Methodol. 2021 Jan 7;21(1):10. doi: 10.1186/s12874-020-01197-3.

引用本文的文献

1
Revising the reproductive story: psychosocial and reproductive impacts 12 months after reproductive genetic carrier screening.重塑生育故事:生殖遗传携带者筛查12个月后的心理社会和生殖影响
Eur J Hum Genet. 2025 Jul 9. doi: 10.1038/s41431-025-01903-z.